Avista Pharma Solutions has completed facility upgrades that double the company’s active pharmaceutical ingredient (API) manufacturing capacity at its Longmont, CO site. During this expansion, the site’s three existing GMP drug substance manufacturing suites were upgraded, and a fourth GMP suite was added. The facility’s non-GMP capacity was also doubled with the addition of two large-scale development suites. Among the new equipment installations were four walk-in hoods, three 50-gallon glas...